REVIEW OF ETOPOSIDE SINGLE-AGENT ACTIVITY

被引：78

作者：

SCHMOLL, H

机构：

来源：

关键词：

D O I：

10.1016/S0305-7372(82)80074-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：21 / 30

页数：10

共 71 条

[21] DORR R, 1980, CANCER CHEMOTHERAPY
[22] DORR RT, 1979, AM J INTRAVENOUS THE, V20, P42
[23] DOUGLASS HO, 1979, CANCER TREAT REP, V63, P1355
[24] EAGAN RT, 1976, CANCER TREAT REP, V60, P949
[25] EAGAN RT, 1978, CANCER TREAT REP, V62, P843
[26] EVALUATION OF VP-16 AND COMBINATION OF ADRIAMYCIN AND VINCRISTINE IN ADVANCED BREAST-CANCER
EAGAN, RT
AHMANN, DL
BISEL, HF
[J]. ONCOLOGY, 1976, 33 (03) : 146 - 148
[27] PHASE-II EVALUATION OF VP-16-213 (NSC-141540) IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA RESISTANT TO ALKYLATING-AGENTS
EDMONSON, JH
DECKER, DG
MALKASIAN, GD
WEBB, MJ
JORGENSEN, EO
[J]. GYNECOLOGIC ONCOLOGY, 1978, 6 (01) : 7 - 9
[28] FALKSON G, 1975, CANCER, V35, P1141, DOI 10.1002/1097-0142(197504)35:4<1141::AID-CNCR2820350418>3.0.CO
[29] 2-3
[30] VP16-213 AS A SINGLE AGENT IN ADVANCED TESTICULAR-TUMORS
FITZHARRIS, BM
KAYE, SB
SAVERYMUTTU, S
NEWLANDS, ES
BARRETT, A
PECKHAM, MJ
MCELWAIN, TJ
[J]. EUROPEAN JOURNAL OF CANCER, 1980, 16 (09) : 1193 - 1197